Intellectual Property Rights
Home  »  Community News  »  Intellectual Property Rights
Jun
25
ragupathyrenganathan
Evaluating and improving orphan drug regulations in Europe: A Delphi policy study
Intellectual Property Rights
0
Jun
25
ragupathyrenganathan
The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?
Intellectual Property Rights
0
Jun
25
ragupathyrenganathan
Priority setting for orphan drugs: An international comparison
Intellectual Property Rights
0
Jun
1
ragupathyrenganathan
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
Intellectual Property Rights, Regulatory Affairs
0
Jun
1
ragupathyrenganathan
To study the problems faced by innover from conception idea to filling patent in Indian pharmaceutical industry
Intellectual Property Rights
0

Jun
1
ragupathyrenganathan
The effects of patent-law changes on innovation: The case of India’s pharmaceutical industry
Intellectual Property Rights
0

Jun
1
ragupathyrenganathan
To Study The Scope & Importance Of Amended Patent Act On Indian Pharmaceutical Company With Respect To Innovation
Intellectual Property Rights
0

Jun
1
ragupathyrenganathan
An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors
Intellectual Property Rights
0

Jun
1
ragupathyrenganathan
The face of the patent is not the ‘‘Whole Story’’: determining effective life of a pharmaceutical patent in the United States
Intellectual Property Rights
0

Jun
1
ragupathyrenganathan
Evergreening, patent challenges, and effective market life in pharmaceuticals
Intellectual Property Rights
0